This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.